Introduction
Polymorphism in molecular crystals is an important area of research due to increasing interest within the pharmaceutical industry. A change in crystalline structure can cause properties to differ between polymorphs, and these may have either beneficial or detrimental effects on a drug's method of action 1 . Polymorphism is also an important issue for the protection of intellectual property 2, 3 , and so for all of these reasons a complete description of all possible polymorphs is now recommended by Federal Food and Drug Administration (FDA) regulations 4 .
Paracetamol provides an example of a popular and widely used Active Pharmaceutical Ingredient (API) that can exhibit polymorphism. Three polymorphs of this compound have been obtained at ambient pressure, and all have different physical properties that are related to the differences in crystal structures [5] [6] [7] . The monoclinic form I is the thermodynamically stable form at ambient pressure 8 , whereas the denser orthorhombic form II becomes thermodynamically stable at high pressure [9] [10] [11] . Two additional polymorphs were recently reported to form reversibly at very high (above 8 GPa) pressures 12 . Among the drawbacks of paracetamol for medical applications is its hepatotoxicity [13] [14] [15] [16] . There is evidence that an isomeric compound, metacetamol (N-acetylmeta-aminophenol) 17 (Scheme 1), is significantly less toxic [18] [19] [20] [21] , although recent studies 23 make this statement questionable reporting that metacetamol may also be hepatotoxic like paracetamol. Although various biological studies have been published for metacetamol [22] [23] [24] , nothing has yet been documented on the potential presence of polymorphic forms. Only one form has been described; its crystal structure has been solved 17 , but no studies of its vibrational spectra or thermal properties have been reported.
The aim of this study was to investigate the polymorphism of metacetamol. In this work it was shown that another polymorph, form II, can be obtained from the melt in a reproducible manner. The bonding and stability of metacetamol form II was investigated thoroughly in relation to its crystal structure using a variety of relevant techniques, including thermal analysis and calorimetry, vibrational spectroscopy, UV-Visible spectroscopy, and X-ray diffraction.
Materials
Metacetamol was purchased from Sigma-Aldrich (form I) and was used after recrystallization from water. Depending on the procedure, purified single crystals or polycrystalline samples of form I were obtained. Form II was produced from recrystallized form I using procedures described later in the text.
Characterisation
X-ray powder diffraction. All polycrystalline samples were examined using a Bruker GADDS diffractometer: Cu Kα radiation (λ = 1.5418 Å), 5 1.5418 Å, 16412 reflections measured, 5281 unique (R int = 0.0888) which were used in all calculations. The final wR 2 was 0.3430 (all data) and R 1 was 0.1078 (I > 2(I)).The poor quality of the very fragile and highly labile crystals accounts for the high values of R int and R 1 .
Differential Scanning Calorimetry (DSC).
Calorimetric measurements were performed using a DSC-204 (Netzsch). Samples (9 mg of several small single crystals) were loaded into standard aluminium crucibles and covered with a lid, but not sealed. The heating rate was set to 6 K/min and the cooling rate was varied from 3 to 12 K/min, using liquid nitrogen as a cooling agent. Figure S. 3.).
Infrared
Raman Spectroscopy. Raman spectra were recorded using a LabRAM HR 800 spectrometer from HORIBA JobinYvon with a CCD detector. For spectral excitation, the 488 nm line of an Ar + laser was used with a beam size of ~1 μm on the surface of the sample and a power of ~8 mW. All data were collected using a Raman microscope in backscattering geometry. For the sample of form I, polarization was used along the mm and ll directions. Form II was examined without using polarized radiation as it could only be studied as a polycrystalline sample.
UV-Vis Optical Spectroscopy. UV-VIS spectra were recorded using a Cary 60 UV-Vis spectrophotometer from Agilent Technologies, equipped with Agilent Cary 60 REMOTE DRA MVIDEO solid state auxiliary unit. All spectra were recorded in the range 200-800 nm with a resolution of 2 nm at a scan rate of 600nm/min.
Chromatography. Chromatographic analysis of the samples was performed using an HPLC Agilent 1200 equipped with a Zorbax SB-C18 (2.1x150mm, 3.5 µm) column used in conjunction with DAD (H 2 O-MeOH (30%-100%, 2-22')) and a GC-MS Agilent GC 6890 equipped with a MSDetector 5973N. Chromatography studies (HPLC and GC-MS) were performed to check the purity of metacetamol form I samples after recrystallisation from water and for form II after its preparation as described below. For all samples the purities proved to be greater than 99%.
Results and Discussion

Preparation of form II
Trial crystallisation studies from solution using common solvents (water, acetone, ethanol, ethyl acetate, THF, dioxane) produced only form I of metacetamol. From previous research it was known that form II of paracetamol could be produced under certain conditions from the melt 5 and so our studies on metacetamol also focused on the melt. A sample of form I was placed into a melting point apparatus (BÜCHI M-560) and heated to just above the reported melting point of 422 Kat a rate of 5 K/min until all traces of solid material had disappeared. The sample was then cooled down to 298 K at a rate of approximately 5 K/min. It was observed that the sample sub-cooled to give an optically transparent glass. On heating this glass a rate of 5 K/min, the glass was observed to crystallize at ~360 K to give a polycrystalline solid which subsequently melted at ~403 K. The difference of ~20 K in the melting points strongly suggested the existence of new polymorph that has significantly lower lattice energy. In order to produce larger quantities of this new form (henceforth denoted form II), a scaledup experiment was conducted using a Petri dish (diameter of 50 mm, 10 mg of sample) and a hotplate. However, this method was Please do not adjust margins
Please do not adjust margins unsuccessful as the heating-cooling process was difficult to control, and invariably resulted in the formation of form I (identified by PXRD). Nevertheless, this experiment did confirm that the heating process did not result in thermal decomposition of the sample. In the next series of experiments a sample (100 mg) was heated in a sealed glass vial in an oil bath (up to 428 K at a rate of 2 K/min, followed by cooling to ambient temperature at an average rate of 0.5 K/min). The heating of the sample was uniform, in order to minimise the likelihood of unwanted seeds of the undesirable form I, and contact with airborne contaminants was minimised. This method proved to be successful in producing form II as a polycrystalline powder, but it failed to produce single crystals. By using a programmable sublimation apparatus (BÜCHI B-585), form II was also successfully and reproducibly obtained, as heating and cooling rates were readily controlled (heating to 430 K at a 5 K/min and cooling at 0.4 K/min). Contact with air was also reduced using this apparatus as the experiment was performed under reduced pressure (16 mbar) in this device using a vacuum pump (BüCHI V-700) with vacuum controller (BüCHI V-850). No sublimation was observed under these conditions. Both methods produced a polycrystalline material. UV/Visible spectra of the samples of solid forms I and II recorded without grinding were essentially identical (Supp. Figure S1 ).
Thermogravimetric analysis (TGA) of samples of both forms I and II showed negligible mass loss up to the melting point ( Fig. 1,a) , confirming that form II is not a solvate and that no significant thermal decomposition had occurred.
Form I obtained by recrystallisation from aqueous solution contained about 1.4 % mass of solvent inclusions, as estimated from the presence of a small peak at ~273 K in the DSC curves ( Fig.  1,b ) combined with the TG data (Fig 1,a) , which can be interpreted as melting of frozen inclusions of crystallisation liquor in the crystals. This is a very low value compared with many other organic crystals grown from solution 28 .The presence of solvent inclusions is important to consider when discussing the stability of crystalline material on storage. It has been shown previously for paracetamol that these inclusions trigger the phase transformation of paracetamol II into paracetamol I on storage at ambient conditions and on heating 29 . On the contrary paracetamol II grown from the melt without solvent inclusions, melts without showing a polymorphic transition 8 .The DSC trace shown in Fig. 1,b shows that form I of metacetamol melts at approximately 420.5 K. On cooling the melt at 6 K/min, a substantial degree of sub-cooling was observed until an exothermic recrystallisation peak was observed over the range 363 -340 K. On reheating, a melting peak was observed at 400 K, corresponding to the melting point of form II. These results are in agreement with the optical observations of samples in the melting-point apparatus, and indicate that form II crystallizes from the sub-cooled melt. 
X-ray powder diffraction studies
Fig . 2 shows the diffraction patterns recorded for (1) a lightly ground sample of form I (2), a lightly ground sample of form II crystallised from the melt, and (3) a sample crystallised from the melt using the sublimation apparatus as described above with no grinding or mixing. The diffraction pattern of the film produced using the sublimation apparatus was similar to that measured for the lightly ground sample obtained from the melt, and both patterns are clearly different from form I. Furthermore, these experiments demonstrate that form II can be prepared without contamination from form I. The higher background scattering observed in pattern (3) is caused by the presence of amorphous material that has not recrystallised. The observed differences in peak intensities between patterns (2) and (3) can be explained by preferred orientation associated with sample (3)
Using the procedure developed for preparing pure samples of form-II from the melt, it was possible to collect X-ray powder diffraction data on Beamline I11 25 at the Diamond Light Source (see Experimental Section above). The diffraction pattern recorded at 298 K is displayed in Fig. 3 and is in broad agreement with those obtained from the laboratory instrument. On account of the exceptionally high resolution available from this instrument, it was possible to index this pattern using the program DASH 30 
Single crystal X-ray diffraction study
On account of the difficulties associated with solving the structure from X-ray powder diffraction data, attempts were made to grow single crystals of form II from a selection of common solvents. All of these attempts failed and so a different approach was adopted that was based on work described by Capes and Cameron in which the metastable orthorhombic form of paracetamol was obtained by the phenomenon of "contact-line crystallisation" 31 . A similar approach has also been used to grow single crystals of the highly metastable β-form of RDX 32 . In both cases, single crystals of the metastable forms grew at a solvent-air interface. In the current study, we modified this procedure to create an interface between water and hexadecane -a high-boiling, water-immiscible liquid. An aqueous solution of metacetamol (saturated at ~70 °C) was heated to its boiling point in order to remove any possible seed crystals of form I. Whilst still hot, a layer of hexadecane was added to the vial, and on cooling to ambient temperature thin, plate-like crystals formed at the interface of the aqueous and organic phases. Provided that the crystals of form II were retained in the crystallisation medium in a sealed vial, they appeared to be stable for a period of several days. However, if agitated in an open vial, they rapidly transformed to form I.The crystals were mechanically very fragile and rapidly transformed to form I unless they were handled very carefully. The crystals also diffracted poorly and hence the quality of the diffraction data was not optimum. Nevertheless, it proved possible to solve the structure in space group P2 1 using direct methods. The poor quality of the intensity data is quite obvious on inspection of a displacement ellipsoid plot: all ellipsoids are oriented in the same direction and all are quite significantly prolate. A strong similarity restraint (RIGU in ShelXL) was used to prevent several atoms from becoming non-positive definite during anisotropic refinement. The possibility of twinning was investigated, but we could not integrate the data assuming the crystal to be twinned as the reflections were too smeared out to identify a definitive second component. Integration using the option "follow significant sample movement" gave a significantly better refinement.
The calculated powder diffraction pattern based on the model obtained from the single-crystal diffraction matched well the experimental patterns obtained for polycrystalline samples (Fig. 3) , confirming that the bulk material obtained from the melt is the same form as the single crystals grown at the water/hexadecane interface.
The crystal structure of metacetamol form II is remarkable (Fig. 4) . In contrast to form I 17 corresponding to a density of 1.378 g/cm 3 at 120 K. The densities being practically the same, one can suppose that form II is metastable because of weaker directional intermolecular interactions, such as hydrogen bonds. It is well known that even denser forms of molecular crystals can be less stable, if denser packing actually results in weaker or fewer hydrogen bonds. Such an effect has been observed for the polymorphs of paracetamol, where the denser form is less stable at ambient pressure 8, 33 .
Polymorph II of metacetamol belongs to high Z' crystal structures. Pseudosymmetry is frequently encountered in such cases and it seems to be also present here [for (010) layers slightly distorted p 2 1 /c 1 1 layer group symmetry with Z'=1]. Additionally, this pseudosymmetry can most probably be related to the crystal twinning.
Vibrational spectroscopy
Vibrational spectroscopy provided complementary insight into the properties of the hydrogen bonds in the new polymorph. Raman spectra recorded for both forms on cooling from 295 K to 5 K in steps of 20 K are shown in Figure 5 .The main difference between the spectra of the two forms in the higher wavenumber ranges in the positions of the N-H stretching modes (3325 cm -1 for form I and 3400 cm -1 for form II at 295 K). This is consistent with the crystal structure of form II in which the N-H groups are not involved in any hydrogen bonds. Slight differences in the O-H..O vibrational modes were also observed -bands at 3104cm -1 and 3123 cm -1 for forms II and I, respectively. Differences in the low wavenumber range below 1000 cm -1 can also be discerned, thereby providing an additional means of distinguishing the two forms 34 . The Raman spectra collected at variable temperature show that no phase transitions occur on cooling either Form I or Form II (Fig.5) . Infrared spectroscopy was used to complement the Raman spectroscopic studies, in particular to follow the vibrations of the NH-groups. A large difference in the spectra in this region was observed for metacetamol I and II. A band at 3327 cm -1 (298 K) in the spectrum of form I (Figure 6 a,b) could be assigned to the N-H stretching mode, when compared to the gas phase spectra calculated in Gaussian09 The range between 1350-1550 cm -1 contains several modes that could be assigned to combined frequencies of δ CNH with υ Ph and υ CO by analogy with paracetamol 36 . Displacement of these bands also correlates with the change in vibration of the NH-group due to the absence of H-bonds. Another difference present in the "fingerprint region" of IR spectra (below 1000 cm peculiarity for metacetamol II was discovered -the appearance of the band at 3952cm -1 (probably, a combination band), which was not observed in the spectra of metacetamol I, which can also be explained by the change in N-H group bonding. In general, with the exception of the NH-vibrations, the IR-spectra of both forms of metacetamol are very similar, thus providing evidence that vibrations of other functional groups are not affected much by the change in molecular packing
Transitions between metacetamol forms I and II
In order to follow the transition from form I to the melt followed then by recrystallizsation to form II in situ, we used IR-spectroscopy and DSC. The characteristic peak associated with the N-H stretching mode observed at 3325 cm -1 in the infrared spectrum of form I was no longer visible in the spectrum of the melt (Fig.7) . Instead, a broad absorption over the region 3000-3500 cm -1 was observed.
When the experiment was carried out under dry N 2 , no crystallizsation of the melt was observed upon cooling or upon subsequent storage at 298 K for up to 12 hours. By contrast, when air was allowed to diffuse slowly into the container, crystallisation of melt into form II at 298 K occurred after approximately one hour and this resulted in the appearance of the N-H stretching mode at 3400 cm -1 , characteristic of form II (Fig. 7 ). The transition to form II was also confirmed by measuring the melting temperature of the sample (399.5 K) with DSC. The effect of cooling rate was not studied during the IR experiment. The storage temperature apparently did not have any pronounced effect on the transition. On heating, form II to its melting point under dry N 2 , the melt did not crystallise (instead, it remained amorphous) after cooling over a period of at least a week (the maximum observation time). After the N 2 was replaced by air, the crystallisation of the amorphous form to form II could be observed (Figure 8 ). During the variable-temperature IR-spectroscopy experiments, the sample partially sublimed and condensed onto the glass slide covering the cell. After the experiment, this cover slide was removed and the IR-spectrum of the condensed sample was recorded. The presence of both forms of metacetamol was confirmed by the IR-spectrum ( Figure 9 ). The sample was also inspected visually under the optical microscope, and this gave clear evidence that polycrystalline form II was present alongside crystals of form I (Figure 10 ). The behaviour and appearance of metacetamol form II is rather similar to that of the "elusive" paracetamol form III: both substances form drops with a large number of small crystallites radiating from the centre to borders of the drop The presence of air, and in particular moisture in the air, had a noticeable effect not only on the crystallisation of form II from the melt, but also on the transformation of form II to form I. This was demonstrated in an experiment in which a sample of form II was divided equally into three portions which were stored under different levels of relative humidity. Samples were monitored over a period of ~5 days, and X-ray powder diffraction patterns were measured at 24-hour intervals ( Figure 11 ). To simulate humid conditions the sample contained in a diffractometer sample holder was placed under a jar (12 x 12 x 6 cm) alongside a vial containing ~10 ml water. Ambient relative humidity of 50-60 % conditions were achieved by leaving the loaded sample holder exposed to the laboratory atmosphere. The third sample holder was placed inside a sealed desiccator with anhydrous calcium chloride used as the dessicant. The sample stored under dry conditions remained as pure form II over the study period, but the sample stored under humid conditions, to form I within 24 hours. Sample stored at ambient humidity also undergo transition to form I but slower. In this respect, it is worth noting that a transformation of paracetamol II to paracetamol I is also facilitated in the presence of water vapour, whereas dry samples can be preserved indefinitely long 8, 37 . 
Conclusions
A new polymorph (Form II) of metacetamol has been identified and characterised using a range of techniques. Form II can be crystallised from the melt or at the interface of an aqueousorganic layer. Form II exhibits a very different crystal packing from either Form I or any of the known polymorphs of paracetamol. This polymorph can be formed under certain conditions from the melt. It is highly unstable in the presence of even small amounts of water in the air, but can be preserved indefinitely long in dry atmosphere. In this respect, metacetamol II behaves similar to the orthorhombic paracetamol II.
Metacetamol II melts at a significantly lower temperature than Form I and has a lower lattice energy despite having a very close density. This can be explained by consideration of its crystal structure in which metacetamol molecules form dimers linked by OH…O hydrogen bonds, whereas the N-H bonds of the amide groups are not involved in any hydrogen bonds. One would expect that Form II has a higher aqueous solubility than Form I and hence a higher bioavailability. Further studies
